Sample 02 — Nanofibrous Wound Dressing (Controlled Release)
An advanced biocompatible nanofibrous wound dressing concept with high surface area and active pharmaceutical delivery, developed in collaboration with Kimia Zist Tarmim Co.
Technical Specification Summary (L-Diagram Metrics)
Compliant with ISO 16890, EN 779:2012 & EN 1822Product Technical Data Tabs
Engineering Overview & Functional Architecture
Developed as part of our strategic B2B collaboration with Kimia Zist Tarmim Co., this platform replicates the native extracellular matrix (ECM) architecture, promoting cellular migration, moisture retention, exudate absorption, and antimicrobial barrier protection.
Verified Standards & Compliance Certifications
- DIN 53438-F1: Self-extinguishing fire-retardant media classification.
- UL Class 1 / UL 900: Underwriters Laboratories smoke and flammability compliance.
- R0 Particle Migration Rating: 100% paint defect prevention without lint shedding in down-draft spray booths.
- High Burst Pressure Resistance: Structural integrity verified up to > 6000 Pa burst pressure differential.
Technical Parameters & Operating Limits
| Parameter | Verified Value / Standard |
|---|---|
| Biomedical Matrix | Biocompatible Synthetic/Natural Polymer Blend |
| Drug Delivery Capability | Active pharmaceutical ingredient (API) loading |
| Collaborating Partner | Kimia Zist Tarmim Co. |
| Fiber Diameter | 80–500 nm (ECM-mimetic scale) |
| Porosity & Exudate Control | High gas permeability with moisture barrier |
| Production Line Width | 60 cm (Roll-to-Roll) |
| SKU Code | Dimensions W×L×D (mm) | Filter Class | Airflow (m³/h) | Initial ΔP (Pa) | Rec. Final ΔP (Pa) | Area (m²) | Action |
|---|---|---|---|---|---|---|---|
NSAN-S02-60CM
|
Roll 600mm x 25m | — | — | 450 | 15.0 |
Engineered Advantages & Performance Benefits
ECM Architecture Replication
Mimics the extracellular matrix to accelerate epithelial tissue regeneration.
Sustained Drug Release
Maintains therapeutic drug concentrations directly in the wound bed over 24–72 hours.
Bacterial Exclusion
Nanoscale pore size stops external bacterial penetration while allowing oxygen exchange.
Target Industries & Deployment Sectors
Chronic Diabetic Foot Ulcers
Bioactive nanofibrous dressing accelerating closure in non-healing diabetic wounds.
Burn Care & Surgical Incisions
Painless removal dressing preventing secondary tissue trauma upon peeling.
Kimia Zist Tarmim Co. × Nano Sazeh Aryan Nik
Development of active wound healing matrices with controlled therapeutic drug release and biodegradable nanofiber scaffolds under clinical trials.
Frequently Asked Technical Questions
Expert answers regarding installation, operating pressure limits, and nanofiber customization.
How does Sample 02 control active pharmaceutical ingredient (API) release kinetics?
Release rates are programmed by adjusting the electrospun polymer dissolution rate, core-shell fiber geometry, and drug-polymer interaction parameters.
Who validated the clinical concept behind Sample 02?
The functional dressing concept is developed in collaboration with Kimia Zist Tarmim Co. (Next-generation nanofibrous wound dressings).
Can the nanofibrous dressing be sterilized using gamma radiation?
Yes. Formulations are developed to withstand standard gamma irradiation or ethylene oxide (EtO) sterilization protocols without morphology degradation.
What is the roll width available for automated medical converting?
Rolls are produced up to 60 cm wide, compatible with standard high-speed medical slitting, pouching, and packaging machines.
Inquire Technical Specs & Pricing for NSAN-S02
Our senior filtration and electrospinning engineers will review your operating parameters and reply with a formal quotation within 24 hours.